Back to Search
MARK SELIGMAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1528061173Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD11837(OR)
Research & Publications (20)
Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values.
PMID 17229418·Clin Chim Acta·2007
8-other
The prevention of depressive symptoms in low-income, minority children: two-year follow-up.
PMID 16643843·Behav Res Ther·2007
2-rct
School-based prevention of depressive symptoms: A randomized controlled study of the effectiveness and specificity of the Penn Resiliency Program.
PMID 17295559·J Consult Clin Psychol·2007
2-rct
Preventing co-occurring depression symptoms in adolescents with conduct problems: the Penn Resiliency Program.
PMID 17347362·Ann N Y Acad Sci·2006
8-other
Self-discipline outdoes IQ in predicting academic performance of adolescents.
PMID 16313657·Psychol Sci·2005
8-other
[Development of the Japanese version of the Values In Action Inventory of Strengths (VIA-IS)].
PMID 16447695·Shinrigaku Kenkyu·2005
8-other
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
PMID 15726517·Semin Oncol·2004
3-trial
A test of integration of the activation hypothesis and the diathesis-stress component of the hopelessness theory of depression.
PMID 15169613·Br J Clin Psychol·2004
8-other
Strengths and satisfaction across the adult lifespan.
PMID 15151189·Int J Aging Hum Dev·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5050 NE HOYT ST, STE 362
PORTLAND, OR 97213 - Phone
- (503) 232-7000
Quick Facts
- NPI
- 1528061173
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile